<DOC>
	<DOCNO>NCT02384018</DOCNO>
	<brief_summary>The purpose study show safety tolerability mesenchymal stromal cell ( MSCs ) product autologous nature , expand use non-xenogeneic , human component expansion medium ( pool human platelet lysate ) deliver fresh . Subsequently , investigator intend test whether infusion MSCs immediately islet autograft reduce onset diabetes improve glycemic control total pancreatectomy islet autotransplantation .</brief_summary>
	<brief_title>Mesenchymal Stem Cell Islet Co-transplantation</brief_title>
	<detailed_description>This Phase I study evaluate safety tolerability autologous BM-MSCs chronic pancreatitis patient undergo total pancreatectomy islet autotransplantation ( TP-IAT ) . CCT-BMMSC infuse one follow dos : ( Tier 1 ) , 20x10^6 cell per patient , ( Tier 2 ) , 50x10^6 cell per patient , ( Tier 3 ) , 100x10^6 cell per patient . Primary objective : To describe compare safety tolerability infusion fresh autologous bone marrow-derived Mesenchymal stromal cell islet transplantation chronic pancreatitis patient undergo TP-IAT . The investigator plan enroll 24 patient whole study . The duration study 12 month . The investigator anticipate study complete within 2 year commencement . Secondary objective : Efficacy infusion fresh autologous bone marrow-derived Mesenchymal stromal cell together islet transplantation chronic pancreatitis patient undergo TP-IAT assess onset diabetes , glycemic control , pain relief quality life index . Safety variable : Adverse event ( AEs ) , Laboratory parameter ( hematology , biochemistry , urinalysis ) , Vital sign</detailed_description>
	<mesh_term>Pancreatitis</mesh_term>
	<mesh_term>Pancreatitis , Chronic</mesh_term>
	<criteria>Chronic pancreatitis patient undergo TPIAT . &gt; 18 year age . Patients BMI 18.5 30 . Renal function : &gt; 90mls/min/1.73m square Normal INR/PT/PTT value MUSC clinical laboratory standard Diabetes free surgery ( fast blood glucose &lt; 125mg/dl ) . No prior pancreatic surgery exception transduodenal sphincteroplasty Whipple/Beger procedure . Patients normal liver function measure serum level aminotransferase include alanine aminotransferase ( ALT ) , aspartate aminotransferase ( AST ) , total bilirubin level . Patients whose Hemoglobin , Hematocrit , Platelet count normal value MUSC clinical laboratory standard . Patients hematological malignancy . Patients immunosuppression . Patients marked calcification disease CT scan . Patients severe fibrosis atrophy pancreas MRI .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>